NCBiotech News

Chapel Hill-based TARGET PharmaSolutions, a clinical data company focused on real-world evidence in disease studies, has formed a strategic partnership with Gilead Sciences to better understand two major liver disorders.

Cambrex Corp., a contract manufacturer of small-molecule therapeutics with a growing facility in High Point, has signed an agreement to acquire Avista Pharma Solutions, a contract development, manufacturing and testing organization (CDMO) in East Rutherford, N.J., for about $252 million.

Seqirus, already the world’s largest producer of cell-based influenza vaccines, is about to grow even larger due to strong global demand for its quadrivalent flu vaccine.

Durham-based Ribometrix, a developer of small-molecule therapeutics that target ribonucleic acid (RNA), has raised $30 million in Series A financing.​​​​​​​

Pairwise, a gene editing and plant technology start-up, is establishing its headquarters in leased space on the Golden Belt Campus in the heart of downtown Durham.

The NIH's National Center for Advancing Translational Sciences has announced new SBIR and STTR funding opportunities for entrepreneurs aiming to commercialize innovations.

North Carolina’s entrepreneurial companies had an opportunity to learn more about alternative funding sources through the venture arms of disease foundations at "Invest in Cures," a Larger Than Life Science event series forum.

Deerfield Management, an investment management, information and philanthropy firm, has given the University of North Carolina at Chapel Hill an injection of up to $65 million to spur drug discovery and development.

Durham-based BioAgilytix, a fast-growing provider of bioanalytical testing services for large-molecule drugs, will be acquired by a privately held Belgian investment company.

Fortune 500 medical technology firm acquires Durham-based company and keeps manufacturing of biosurgical sealant device in North Carolina.

The challenge of developing new drugs to treat serious lower gastrointestinal disorders just got easier to digest for Symberix, a Durham biopharmaceutical company.

The road to better health is only a simple blood test away, thanks to a new consumer wellness package offered by Burlington-based global life sciences company LabCorp.

Advanced Animal Diagnostics (AAD) of Morrisville has entered into a license and commercialization agreement with Zoetis, the world’s largest animal-health company, to bring AAD’s mastitis-detection technology to dairy producers and veterinarians outside of the United States. 

Patients wanting easy access to their lab test results from LabCorp can now get them through their smart phones.

Precision health took center stage in North Carolina recently as Duke University hosted its second Precision Medicine World Conference (PMWC). The event attracted more than 400 experts who represented health and biotechnology organizations from around the world.